We are live on ! Find out more
CYTH

Cyclo Therapeutics, Inc. Common Stock
CYTH

Delisted

CYTH was delisted on the 25th of March, 2025.

Back to rankings

13 hedge funds and large institutions have $2.23M invested in Cyclo Therapeutics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

67% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 3

8% more funds holding

Funds holding: 12 → 13 (+1)

17% less capital invested

Capital invested by funds: $2.7M → $2.23M (-$462K)

Holders
13
Holders Change
+1
Holders Change %
+8.33%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
3
Closed
1
Calls
$2.36M
Puts
–
Net Calls
+$2.36M
Net Calls Change
+$2.36M

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$225K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$158K
3
Two Sigma Advisers
Two Sigma Advisers
New York
+$95.4K
4
Renaissance Technologies
Renaissance Technologies
New York
+$82K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$69.4K

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$118K
2
Morgan Stanley
Morgan Stanley
New York
-$7.04K
3
ASN
Advisory Services Network
Georgia
-$1K
4
Wells Fargo
Wells Fargo
California
-$8

CYTH Hedge Fund Activity: Q3 2021 in Review

13 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Cyclo Therapeutics, Inc. Common Stock (CYTH) for Q3 2021, worth a combined $2.23M — down 17% from $2.7M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new CYTH positions and 1 closed out — a net gain of 1 holder — while 5 added to existing stakes and 3 trimmed.

The largest buyer was UBS Group, adding an estimated $225K. The largest seller was State Street, cutting an estimated $118K.

  • 13 institutional investors held Cyclo Therapeutics, Inc. Common Stock (CYTH) as of Q3 2021, up from 12 in Q2 2021.
  • Funds reported $2.23M of Cyclo Therapeutics, Inc. Common Stock stock for Q3 2021, down 17% quarter-over-quarter.
  • 2 funds opened new Cyclo Therapeutics, Inc. Common Stock positions in Q3 2021 and 1 closed out, a net change of +1 holder.
  • The largest Cyclo Therapeutics, Inc. Common Stock buyer in Q3 2021 was UBS Group, an estimated $225K added.
  • The largest Cyclo Therapeutics, Inc. Common Stock seller in Q3 2021 was State Street, an estimated $118K sold.

Based on aggregated 13F filings for Q3 2021.